Miller James Charles

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -17% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Miller James Charles's trades of Recro Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
203.03
Quantity 10,775 -22.2%
Value US$1,958,019
Transaction date
Purchase
Price
333.95
Quantity 42,030 +46.8%
Value US$4,257,518
Transaction date
Purchase
Price
409.84
Quantity 86,410 +24.3%
Value US$4,312,849
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-28 2023-08-28
B Purchase
10,775 -22.2%
203.03
US$1,958,019 		10,775 -22.2% 203.03 US$1,958,019
2022-03-22 2022-03-18
B Purchase
42,030 +46.8%
333.95
US$4,257,518 		42,030 +46.8% 333.95 US$4,257,518
2021-11-19 2021-11-17
B Purchase
86,410 +24.3%
409.84
US$4,312,849 		86,410 +24.3% 409.84 US$4,312,849